JBIO Stock Price, Chart, Stats & News
Jade Biosciences, Inc. (JBIO) is a dividend-paying stock with a current dividend yield of 0.00% as of Jun 30, 2026. It pays $0 per share over the trailing twelve months and distributes annually.
Dividend safety
Dividend coverage looks healthy — JBIO pays out about 0% of earnings.
JBIO chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.06% |
ROA | -36.43% |
ROE | -64.64% |
D/E | 0.00x |
Interest coverage ratio | – |
JBIO valuation
P/E | – |
P/S | – |
P/B | 2.85x |
P/CF | -9.17x |
P/FCF | -4.22x |
P/OCF | -9.17x |
PEG | -0.14x |
EV multiple | -5.54x |
About
Jade Biosciences, Inc. operates as a biotechnology enterprise, primarily focused on pioneering superior therapeutic solutions for significant unmet medical requirements in autoimmune disorders. Its leading development candidate, JADE-001, specifically targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway, aiming to treat immunoglobulin A (IgA) nephropathy. Clinical trials for JADE-001 are slated to commence in the latter half of 2025, with initial results projected for the first half of 2026.
Related lists
Similar securities
Based on sector and market capitalization
